Business
Vanda Pharmaceuticals Announces Participation at Evercore ISI's Catalyst Day
WASHINGTON, Oct. 14, 2021 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it will participate at Evercore ISI's
About this update from Vanda Pharmaceuticals Inc.
[{"type":"text","content":"WASHINGTON, Oct. 14, 2021 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it will participate at Evercore ISI's Catalyst Day on Monday, October 18, 2021. Mihael H. Polymeropoulos, M.D., Vanda's President, CEO and Chairman of the Board, will take part in a virtual fireside chat at 1:30 PM ET.\nAbout Vanda Pharmaceuticals Inc.\nVanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on Twitter @vandapharma.\nCorporate Contact:\nAJ Jones II Chief Corporate Affairs and Communications Officer Vanda Pharmaceuticals Inc. (202) 734-3400 [email protected] \nElizabeth Van Every Head of Corporate Affairs Vanda Pharmaceuticals Inc. (202) 734-3400 [email protected]\nKevin Moran Senior Vice President, Chief Financial Officer and Treasurer Vanda Pharmaceuticals Inc. (202) 734-3400 [email protected]\n View original content:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-evercore-isis-catalyst-day-301400804.html\nSOURCE Vanda Pharmaceuticals Inc.","length":2857,"tagName":"div"}]